To strength the statistical reliability of the previously obtained results, analyses of sPD-L1 levels were performed by combining the data obtained from all cancer patients treated with anti-PD-L1, alone or in combination with anti-CTLA-4, reaching a total of 72 patients. The gene discussed is CD274; the disease is cancer.